Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 35, 2021 - Issue 22
274
Views
4
CrossRef citations to date
0
Altmetric
Research Articles

Chemical constituents from the barks of Melia azedarach and their PTP1B inhibitory activity

, , , , , , & ORCID Icon show all
Pages 4442-4447 | Received 21 Sep 2019, Accepted 08 Feb 2020, Published online: 21 Feb 2020
 

Abstract

One new long-chain ester derivative of trans-ferulic acid 1 and one natural tirucallane-type triterpenoid 2, together with forty known compounds (3-42), were isolated from the barks of Melia azedarach. Their structures were established on the basis of spectroscopic data interpretation. Compounds 7, 9, 10, 12, 13 showed significant inhibitory activities against PTP1B with IC50 values of 13.82 ± 1.29 μM, 13.29 ± 2.26 μM, 20.27 ± 0.52 μM, 24.36 ± 1.25 μM, 15.23 ± 0.6 μM, respectively.

Graphical Abstract

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was financially supported by the National Natural Science Foundation of China under Grant 81360477; State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Guangxi Normal University under Grant CMEMR2018-B03; and National Training Program of Innovation and Entrepreneurship for Undergraduates under Grant 201810601015. The PTP1B inhibitory assay was carried out by the National Centre for Drug Screening, Shanghai.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.